You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloid Malignancy

Showing 1 - 25 of 3,878
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

Not yet recruiting
  • Myeloid Malignancy
  • +4 more
  • Telehealth Serious Illness Care Program
  • Education Control
  • Rochester, New York
    University of Rochester
May 24, 2023

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • +3 more
  • Venetoclax plus RIC
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Oct 12, 2022

Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)

Recruiting
  • Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Mar 14, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Molecular Services and EMR-Lab Integration Application for

    Not yet recruiting
    • Advanced Cancer
    • +2 more
    • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
    • limited genetic testing or no testing
    • Rock Hill, South Carolina
      Carolina Blood and Cancer Care Associates
    Oct 18, 2023

    Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

    Recruiting
    • Hematologic Malignancy
    • Myeloid Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 7, 2022

    AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

    Not yet recruiting
    • AML
    • +11 more
    • (no location specified)
    Aug 14, 2023

    Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

    Recruiting
    • Lymphoid Leukemia, Acute
    • +2 more
    • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    May 24, 2022

    Myeloid Malignancy Trial in Detroit (azacitidine)

    Recruiting
    • Myeloid Malignancy
    • Detroit, Michigan
      Henry ford hospital
    Dec 23, 2021

    Non-Myeloid Malignancy Trial in Beijing (YPEG-rhG-CSF, rhG-CSF/PEG-rhG-CSF)

    Completed
    • Non-Myeloid Malignancy
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Feb 7, 2022

    Myeloid Malignancy Trial in United States (APR-246, Venetoclax, Azacitidine)

    Completed
    • Myeloid Malignancy
    • New Haven, Connecticut
    • +7 more
    Jan 18, 2022

    Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

    Not yet recruiting
    • Graft Vs Host Disease
    • +5 more
    • CliniMACS® device
    • (no location specified)
    Jul 20, 2023

    Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy Trial in China (APG-2575, reduced-dose HHT, standard-dose HHT)

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukaemia
    • Myeloid Malignancy
    • Beijing, Beijing, China
    • +9 more
    Jan 10, 2022

    MDS, Acute Myeloid Leukemia, Myeloid Malignancy Trial in Guangzhou (Sodium stibogluconate)

    Recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • Sodium stibogluconate
    • Guangzhou, Guangdong, China
      First Affiliated Hospital of Jinan University
    Jun 5, 2021

    MDS, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Ann Arbor (Pembrolizumab)

    Terminated
    • Myelodysplastic Syndromes
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Cancer Center
    Nov 1, 2022

    Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Jul 18, 2022

    Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

    Withdrawn
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Sep 26, 2022

    Venetoclax Tablets Crushed and Dissolved Into a Solution

    Not yet recruiting
    • Hematologic Malignancy
    • +18 more
    • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Nov 8, 2023

    Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

    Recruiting
    • Colorectal Cancer
    • +11 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 18, 2023

    P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

    Recruiting
    • P53 Mutation
    • +3 more
    • Shanghai, Shanghai, China
      Hematological department, Shanghai Institute of Hematology, Ruij
    Apr 20, 2021

    The Oronasal Microbiota in Pediatric Oncology Patients

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jan 10, 2022